Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Yuan Shih

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2024
ERBB2 Amplification in NSCLC: How Many Faces?Jin-Yuan Shih
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2008
Leg pains, clubbing of digits and lung mass: what is your call?Jenn-Yu Wu, Jin-Yuan Shih
JTO Clinical and Research Reports|September 30, 2021
Not All EGFR Exon 20 Insertions Are Created EqualYen-Ting Lin, Jin-Yuan Shih
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than OneYen-Ting Lin, Jin-Yuan Shih
JCO Precision Oncology|January 20, 2022
Sustained Partial Response to Afatinib in a Patient With Lung Adenocarcinoma Harboring HER2<sup>V659E</sup> MutationLing-Kai Chang, Jin-Yuan Shih
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 5, 2010
Pericardial pigtail knottingShang-Gin Wu, Jin-Yuan Shih
Carcinogenesis|June 14, 2011
The EMT regulator slug and lung carcinogenesisJin-Yuan Shih, Pan-Chyr Yang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 30, 2025
Response to the comments on "PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study"Ching-Yao Yang, Jin-Yuan Shih
Oncotargets and Therapy|October 28, 2016
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancerJenn-Yu Wu, Jin-Yuan Shih
Molecular Cancer|February 20, 2018
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancerShang-Gin Wu, Jin-Yuan Shih
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2024
ERBB2 Amplification in NSCLC: How Many Faces?Jin-Yuan Shih
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2008
Leg pains, clubbing of digits and lung mass: what is your call?Jenn-Yu Wu, Jin-Yuan Shih
JTO Clinical and Research Reports|September 30, 2021
Not All EGFR Exon 20 Insertions Are Created EqualYen-Ting Lin, Jin-Yuan Shih
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than OneYen-Ting Lin, Jin-Yuan Shih
JCO Precision Oncology|January 20, 2022
Sustained Partial Response to Afatinib in a Patient With Lung Adenocarcinoma Harboring HER2<sup>V659E</sup> MutationLing-Kai Chang, Jin-Yuan Shih
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 5, 2010
Pericardial pigtail knottingShang-Gin Wu, Jin-Yuan Shih
Carcinogenesis|June 14, 2011
The EMT regulator slug and lung carcinogenesisJin-Yuan Shih, Pan-Chyr Yang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 30, 2025
Response to the comments on "PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study"Ching-Yao Yang, Jin-Yuan Shih
Oncotargets and Therapy|October 28, 2016
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancerJenn-Yu Wu, Jin-Yuan Shih
Molecular Cancer|February 20, 2018
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancerShang-Gin Wu, Jin-Yuan Shih
Pageof 28